Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumors

被引:145
作者
Zhou, Jiangbing [1 ,2 ]
Patel, Toral R. [2 ]
Fu, Michael [1 ]
Bertram, James P. [1 ]
Saltzman, W. Mark [1 ]
机构
[1] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06511 USA
关键词
PLGA; Nanoparticle; Gene delivery; RNA interference; SMALL INTERFERING RNA; PLASMID DNA; NUCLEAR-PORE; CELLS; TRANSFECTION; EXPRESSION; MECHANISM; PEPTIDES; THERAPY; RELEASE;
D O I
10.1016/j.biomaterials.2011.09.061
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Therapies based on RNA interference, using agents such as siRNA, are limited by the absence of safe. efficient vehicles for targeted delivery in vivo. The barriers to siRNA delivery are well known and can be individually overcome by addition of functional modules, such as conjugation of moieties for cell penetration or targeting. But, so far, it has been impossible to engineer multiple modules into a single unit. Here, we describe the synthesis of degradable nanoparticles that carry eight synergistic functions: 1) polymer matrix for stabilization/controlled release; 2) siRNA for gene knockdown; 3) agent to enhance endosomal escape; 4) agent to enhance siRNA potency; 5) surface-bound PEG for enhancing circulatory time; and surface-bound peptides for 6) cell penetration; 7) endosomal escape; and 8) tumor targeting. Further, we demonstrate that this approach can provide prolonged knockdown of PLK1 and control of tumor growth in vivo. Importantly, all elements in these octa-functional nanoparticles are known to be safe for human use and each function can be individually controlled, giving this approach to synthetic RNA-loaded nanoparticles potential in a variety of clinical applications. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:583 / 591
页数:9
相关论文
共 37 条
[1]   Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression [J].
Achilefu, S ;
Bloch, S ;
Markiewicz, MA ;
Zhong, TX ;
Ye, YP ;
Dorshow, RB ;
Chance, B ;
Liang, KX .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (22) :7976-7981
[2]  
Allergen Inc, 2011, STUD US INTR INJ SMA
[3]  
Bastos R, 1995, INT REV CYTOL, V162B, P257
[4]   Intravenous Hemostat: Nanotechnology to Halt Bleeding [J].
Bertram, James P. ;
Williams, Cicely A. ;
Robinson, Rebecca ;
Segal, Steven S. ;
Flynn, Nolan T. ;
Lavik, Erin B. .
SCIENCE TRANSLATIONAL MEDICINE, 2009, 1 (11)
[5]   High loading efficiency and tunable release of plasmid DNA encapsulated in submicron particles fabricated from PLGA conjugated with poly-L-lysine [J].
Blum, Jeremy S. ;
Saltzman, W. Mark .
JOURNAL OF CONTROLLED RELEASE, 2008, 129 (01) :66-72
[6]   Targeted Nanoparticles Deliver siRNA to Melanoma [J].
Chen, Yunching ;
Bathula, Surendar R. ;
Yang, Qi ;
Huang, Leaf .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 (12) :2790-2798
[7]   Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides [J].
Chene, Christopher J. ;
Saltzman, W. Mark .
BIOMATERIALS, 2011, 32 (26) :6194-6203
[8]   Structure - Function correlation of chloroquine and analogues as transgene expression enhancers in nonviral gene delivery [J].
Cheng, Jianjun ;
Zeidan, Ryan ;
Mishra, Swaroop ;
Liu, Aijie ;
Pun, Suzie H. ;
Kulkarni, Rajan P. ;
Jensen, Gregory S. ;
Bellocq, Nathalie C. ;
Davis, Mark E. .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (22) :6522-6531
[9]   Ligand-modified gene carriers increased uptake in target cells but reduced DNA release and transfection efficiency [J].
Cu, Yen ;
LeMoellic, Cathy ;
Caplan, Michael J. ;
Saltzman, W. Mark .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2010, 6 (02) :334-343
[10]   Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles [J].
Davis, Mark E. ;
Zuckerman, Jonathan E. ;
Choi, Chung Hang J. ;
Seligson, David ;
Tolcher, Anthony ;
Alabi, Christopher A. ;
Yen, Yun ;
Heidel, Jeremy D. ;
Ribas, Antoni .
NATURE, 2010, 464 (7291) :1067-U140